Niamh Louise Pellegrini's Net Worth
$7.81 Million
Who is Niamh Louise Pellegrini?
Niamh Louise Pellegrini has an estimated net worth of $7.81 Million. This is based on reported shares across multiple companies, which include THORATEC CORP, NEVRO CORP, and Acutus Medical, Inc..
SEC CIK
Niamh Louise Pellegrini's CIK is 0001620611
Past Insider Trading and Trends
2020 was Niamh Louise Pellegrini's most active year for acquiring shares with 6 total transactions. Niamh Louise Pellegrini's most active month to acquire stocks was the month of February. 2020 was Niamh Louise Pellegrini's most active year for disposing of shares, totalling 15 transactions. Niamh Louise Pellegrini's most active month to dispose stocks was the month of September. 2021 saw Niamh Louise Pellegrini paying a total of $146,137.50 for 31,209 shares, this is the most they've acquired in one year. In 2015 Niamh Louise Pellegrini cashed out on 126,555 shares for a total of $6,112,731.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
THORATEC CORP No price found
President, North America
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -40.70K |
$63.50 | -$3,297,428.00 |
0
|
Oct 8
| |||
Form 4
| +47.46% | 13.1K |
—
|
—
| 40.7K |
Mar 16
| |||
Form 4
|
∞
| 27.6K |
—
|
—
| 27.6K |
Oct 13 - Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEVRO CORP (NVRO) Snapshot price: $17.115
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.31% | -1.14K |
$26.45 | -$30,232.35 | 85.97K |
May 28
| |||
Form 4
| +82.13% | 39.28K |
—
|
—
| 87.11K |
Mar 7
| |||
Form 4
| -3.97% | -1.98K |
$33.99 | -$67,266.21 | 47.83K |
Mar 2
| |||
Form 4
| -8.65% | -4.72K |
$31.44 | -$148,333.92 | 49.81K |
Feb 28
| |||
Form 4
| -7.41% | -4.37K |
$47.11 | -$205,635.15 | 54.52K |
Aug 6
| |||
Form 4
| -3.33% | -2.03K |
$71.27 | -$144,749.37 | 58.89K |
Mar 2
| |||
Form 4
| +74.80% | 26.07K |
—
|
—
| 60.92K |
Feb 28
| |||
Form 4
| -11.13% | -4.37K |
$119.73 | -$522,741.18 | 34.85K |
Aug 6
| |||
Form 4
|
—
|
0
|
$106.52 | -$62,347.50 | 39.22K |
Scheduled
|
Mar 10
| ||
Form 4
| +29.31% | 8.89K |
$168.11 | -$118,685.66 | 39.22K |
Mar 2
| |||
Form 4
|
—
|
0
|
$123.75 | -$88,200.00 | 30.33K |
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
$117.38 | -$78,637.50 | 30.33K |
Scheduled
|
Jan 11
| ||
Form 4
|
—
|
0
|
$113.08 | -$72,197.25 | 30.33K |
Scheduled
|
Dec 10
| ||
Form 4
|
—
|
0
|
$117.85 | -$79,350.00 | 30.33K |
Scheduled
|
Nov 10
| ||
Form 4
| -5.65% | -1.82K |
$165.00 | -$299,805.00 | 30.33K |
Scheduled
|
Oct 22
| ||
Form 4
| -3.02% | -1.00K |
$155.00 | -$155,000.00 | 32.15K |
Scheduled
|
Oct 19
| ||
Form 4
| -2.93% | -1.00K |
$107.79 | -$214,890.00 | 33.15K |
Scheduled
|
Oct 9 - Oct 13
| ||
Form 4
|
—
|
0
|
$102.04 | -$55,642.50 | 34.15K |
Scheduled
|
Sep 10
| ||
Form 4
| -11.59% | -4.48K |
$103.24 | -$690,932.52 | 34.15K |
Scheduled
|
Aug 6 - Aug 10
| ||
Form 4
| +16.42% | 5.45K |
—
|
—
| 38.62K |
Mar 2
| |||
Form 4
|
∞
| 33.17K |
—
|
—
| 33.17K |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acutus Medical, Inc. (AFIB) Snapshot price: $0.1761
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +66.82% | 8.4K |
—
|
—
| 20.97K |
Jun 15
| |||
Form 4
| +201.34% | 8.4K |
—
|
—
| 12.57K |
Jun 16
| |||
Form 4
|
∞
| 4.17K |
—
|
—
| 4.17K |
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||